(Q54672530)

2 June 2018

title

Designed ankyrin repeat proteins: a novel tool for testing epidermal growth factor receptor 2 expression in breast cancer. (English)

1 reference

2 June 2018

0 references

4

1 reference

2 June 2018

Andreas Plückthun

8

1 reference

2 June 2018

Holger Moch

9

object named as

Holger Moch

1 reference

2 June 2018

author name string

Jean-Philippe Theurillat

1

1 reference

2 June 2018

Birgit Dreier

2

1 reference

2 June 2018

Gabriela Nagy-Davidescu

3

1 reference

2 June 2018

Silvia Behnke

5

1 reference

2 June 2018

Ursina Zürrer-Härdi

6

1 reference

2 June 2018

Fabienne Ingold

7

1 reference

2 June 2018

publication date

21 May 2010

1 reference

2 June 2018

published in

Modern Pathology

1 reference

2 June 2018

volume

23

1 reference

2 June 2018

issue

9

1 reference

2 June 2018

page(s)

1289-1297

1 reference

2 June 2018

Real-world performance of HER2 testing--National Surgical Adjuvant Breast and Bowel Project experience

cites work

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.103

American Society of Clinical Oncology/College of American Pathologists guideline recommendations for human epidermal growth factor receptor 2 testing in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.103

7 January 2021

Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2.

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.103

7 January 2021

Trastuzumab after adjuvant chemotherapy in HER2-positive breast cancer

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.103

7 January 2021

Adjuvant docetaxel or vinorelbine with or without trastuzumab for breast cancer

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.103

7 January 2021

Trastuzumab plus adjuvant chemotherapy for operable HER2-positive breast cancer

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.103

7 January 2021

HER2 status and benefit from adjuvant trastuzumab in breast cancer

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.103

7 January 2021

HER2 amplification ratios by fluorescence in situ hybridization and correlation with immunohistochemistry in a cohort of 6556 breast cancer tissues

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.103

7 January 2021

HER-2 testing in breast cancer using parallel tissue-based methods

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.103

7 January 2021

HER2 testing by local, central, and reference laboratories in specimens from the North Central Cancer Treatment Group N9831 intergroup adjuvant trial

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.103

7 January 2021

Correction for chromosome-17 is critical for the determination of true Her-2/neu gene amplification status in breast cancer.

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.103

7 January 2021

Concordance between local and central laboratory HER2 testing in the breast intergroup trial N9831

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.103

7 January 2021

Guidelines for human epidermal growth factor receptor 2 testing: biologic and methodologic considerations

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.103

7 January 2021

Directed evolution of a G protein-coupled receptor for expression, stability, and binding selectivity

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.103

7 January 2021

Efficient selection of DARPins with sub-nanomolar affinities using SRP phage display

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.103

7 January 2021

Ribosome display: selecting and evolving proteins in vitro that specifically bind to a target

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.103

7 January 2021

Designing repeat proteins: well-expressed, soluble and stable proteins from combinatorial libraries of consensus ankyrin repeat proteins.

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.103

7 January 2021

Consensus design of repeat proteins.

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.103

7 January 2021

Engineering novel binding proteins from nonimmunoglobulin domains

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.103

7 January 2021

Crystal structure of a consensus-designed ankyrin repeat protein: Implications for stability

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.103

7 January 2021

Characterization and further stabilization of designed ankyrin repeat proteins by combining molecular dynamics simulations and experiments

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.103

7 January 2021

Stabilizing ionic interactions in a full-consensus ankyrin repeat protein

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.103

7 January 2021

Rapid selection of specific MAP kinase-binders from designed ankyrin repeat protein libraries

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.103

7 January 2021

Isolation of intracellular proteinase inhibitors derived from designed ankyrin repeat proteins by genetic screening

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.103

7 January 2021

Selection and characterization of Her2 binding-designed ankyrin repeat proteins

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.103

7 January 2021

A designed ankyrin repeat protein evolved to picomolar affinity to Her2

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.103

7 January 2021

NY-BR-1 protein expression in breast carcinoma: a mammary gland differentiation antigen as target for cancer immunotherapy

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.103

7 January 2021

Efficient tumor targeting with high-affinity designed ankyrin repeat proteins: effects of affinity and molecular size

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.103

7 January 2021

Protein detection using proximity-dependent DNA ligation assays.

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.103

7 January 2021

Characterizing proteins and their interactions in cells and tissues using the in situ proximity ligation assay

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.103

7 January 2021

10.1038/MODPATHOL.2010.103

Identifiers

DOI

1 reference

2 June 2018

1 reference

2 June 2018